⌘K

Login Start Free

Home/Filings/4/0001437749-20-002040

4//SEC Filing

Latkin Jed 4

Accession 0001437749-20-002040

CIK 0000810509other

View on SEC.gov Company Profile

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 4:15 PM ET

Size

5.0 KB

Accession

0001437749-20-002040

Insider Transaction Report

Form 4

Period: 2020-02-06

NAVIDEA BIOPHARMACEUTICALS, INC.NAVB

Interim COO

Transactions

Award
Stock Option
2020-02-06$0.00/sh+100,000$100→ 203,250 total
Exercise: $1.06Exp: 2030-02-06→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]Stock options will vest one-third on each of the first three anniversaries of the date of grant.

Documents

1 file

4
rdgdoc.xmlPrimary
FORM 4

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeother

Related Parties

1

filerCIK 0001554593

Filing Metadata

Form type: 4
Filed: Feb 6, 7:00 PM ET
Accepted: Feb 7, 4:15 PM ET
Size: 5.0 KB

View on SEC.gov